Skip to search formSkip to main contentSkip to account menu

ECO-4601

Known as: TLN-4601 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
This phase II trial was undertaken to evaluate the efficacy of TLN-4601 in patients with glioblastoma (GBM) at first progression… 
2010
2010
2094 Background: TLN-4601 is a structurally novel farnesylated dibenzodiazepinone that has demonstrated broad in vitro… 
Highly Cited
2008
Highly Cited
2008
The novel microbial metabolite diazepinomicin/ECO-4601 (1) has a unique tricyclic dibenzodiazepinone core, which was… 
2007
2007
PurposeECO-4601 is a structurally novel farnesylated dibenzodiazepinone discovered through DECIPHER® technology, Thallion’s… 
2007
2007
14128 Background: ECO-4601 is a structurally novel farnesylated dibenzodiazepinone with broad μM in vitro cytotoxic activity, and… 
2005
2005
Proc Amer Assoc Cancer Res, Volume 46, 2005 5896 ECO-4601 is a structurally novel farnesylated dibenzodiazepinone (MW 462…